2 results
Approved WMOCompleted
Primary Safety Objective * Proportion of patients who complete 24 weeks of combination treatment on pirfenidone at a dose of 1602*2403 mg/d and nintedanib at a dose of 200*300 mg/d Secondary Safety Objective * Proportion of patients who discontinue…
Approved WMOCompleted
The primary objective of the study is to explore and compare the signal strength of different probes for measuring pulse oximetry signals on different body locations. The secondary objective of the study is comparing aspects of user experience (via…